Have a look at our PowerPoint Introduction and Brochure describing deliverables, differentiators and case studies. Eight case studies can also be reviewed.

Method

The main contents of the study were based on sources including in-house databases and an extensive network of contacts in addition to publicly available information (e.g. data from government agencies, patents, scientific journals, trade press, internet etc.). Additional information was sought from other key resources within the industries concerned in sufficient depth to provide accurate analysis and guidance.

CPL used its extensive network of contacts, (including the CPL Executive Search network), to elicit information that would be difficult or impossible for clients to obtain independently Interviews were conducted with those knowledgeable in the industry, both face-to-face and telephone conversations. Contacts were also made at trade-shows.

The report consists of two parts, the summary report and the reference report, to provide the essence of CPL’s findings along with our recommendations, followed by detailed data sources and analysis.

Click to see the contents of the study or look below for an outline.

Table of Contents

Principal Findings

  • PUReOPE Opportunities with Xanthohumol and Related Compounds
  • Supply
  • Players Products and Patent Applications
  • Health Related Benefits
  • Conclusions
  • Recommendations

Background

  • Aging Related Disease
  • XN and Derivatives as an in Vivo Antioxidant
  • Xanthohumol

11 Hop Players and Suppliers

  • Products and Pricing

Recent Articles and News

  • Nematodes and Polyphenols
  • 3 Articles
  • Microbial and Dietary Activation
  • 10 Articles
  • Cognitive Impairment
  • 8 Articles
  • Metabolic Syndrome
  • 8 Articles
  • Phytoestrogen
  • 4 Articles
  • Tissue Related Inflamation
  • 4 Articles
  • Adaptive Inflammation
  • 4 Articles
  • Therapeutics
  • 7 Articles

Patents

4 Tables

6 Figures

Share this project: